First Trust NYSE Arca Biotechnology Index Fund (FBT)
Description
The investment seeks to track the performance of the NYSE Arca Biotechnology (TR). The FBT ETF contains 31 constituents. It is focused on growth holdings in the North America region.
Price $137.06 as of 2022-10-21Cost/Risk/Yield
| Dividend yield | 1.62% |
| Expense ratio | 0.55% |
| Average spread | 0.117% |
| 1Y roundtrip cost | 0.667% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -8.2% | -1.6% | 1.9% | -9.0% | -0.7% | 0.5% | 3.4% | -2.7% | -3.2% | 3.8% | -15.7% | ||
| 2021 | 4.3% | -4.0% | -4.6% | 2.3% | -0.8% | 5.9% | -2.7% | 3.5% | -4.5% | -0.1% | -5.5% | 4.8% | -1.3% |
| 2020 | -4.6% | 1.3% | -8.7% | 15.5% | 9.2% | 1.4% | -1.2% | -3.1% | -2.1% | -2.9% | 5.5% | 4.2% | 14.6% |
| 2019 | 15.8% | 4.5% | 0.4% | -8.2% | -7.4% | 9.8% | -2.9% | -5.8% | -3.9% | 4.9% | 13.1% | 1.3% | 21.5% |
| 2018 | 13.0% | -4.1% | -1.5% | -0.7% | 6.1% | 0.0% | 5.8% | 6.2% | 0.8% | -15.6% | 4.7% | -11.3% | 3.3% |
| 2017 | 5.7% | 8.6% | 1.0% | 2.0% | -2.6% | 9.0% | 1.8% | 7.0% | -0.2% | -2.3% | 3.6% | -0.6% | 32.8% |
| 2016 | -24.1% | -2.9% | 5.1% | 4.3% | 4.6% | -6.3% | 12.1% | -4.4% | 4.1% | -12.8% | 8.8% | -3.9% | -15.6% |
| 2015 | 7.7% | 4.8% | 2.6% | -5.7% | 10.8% | 0.4% | 1.9% | -11.0% | -9.9% | 3.0% | 7.7% | 0.6% | 13.0% |
| 2014 | 8.8% | 10.9% | -8.1% | -2.8% | 2.9% | 7.3% | -1.5% | 14.5% | -1.2% | 8.4% | 2.5% | 0.2% | 41.8% |
| 2013 | 7.7% | 2.4% | 7.2% | 5.7% | 2.9% | -1.5% | 9.5% | -4.1% | 6.0% | -0.8% | 7.0% | 0.6% | 42.6% |
| 2012 | 21.2% | -0.8% | 7.6% | 4.1% | -3.3% | 2.9% | -0.8% | 0.4% | 6.4% | -10.4% | 10.3% | 0.2% | 37.8% |
| 2011 | -1.2% | 0.0% | 6.7% | 6.8% | 1.1% | -1.5% | -7.3% | -11.8% | -7.7% | 6.3% | -8.3% | 1.4% | -15.6% |
| 46.0% | 19.1% | 9.6% | 14.4% | 22.9% | 28.0% | 18.1% | -11.5% | -15.4% | -18.6% | 49.3% | -2.6% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2.21 | 2.21 | |||||||||||
| 2015 | 0.05 | 0.07 | 0.02 | 0.13 | |||||||||
| 2014 | 0.05 | 0.05 | |||||||||||
| 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 2.27 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| ACADIA Pharmaceuticals Inc. | 3.80% |
| bluebird bio, Inc. | 3.76% |
| Regeneron Pharmaceuticals, Inc. | 3.75% |
| BioNTech SE Sponsored ADR | 3.60% |
| Charles River Laboratories International, Inc. | 3.54% |
| BioMarin Pharmaceutical Inc. | 3.51% |
| QIAGEN NV | 3.50% |
| Ultragenyx Pharmaceutical, Inc. | 3.49% |
| Agios Pharmaceuticals, Inc. | 3.48% |
| Incyte Corporation | 3.43% |
| FibroGen, Inc. | 3.43% |
| Bio-Techne Corporation | 3.42% |
| Moderna, Inc. | 3.38% |
| IQVIA Holdings Inc | 3.37% |
| United Therapeutics Corporation | 3.36% |
| Top 15 Weights | 52.82% |
Compare with similar ETFs
| FBT | IBB | IYH | VHT | XBI | XLV | |
|---|---|---|---|---|---|---|
| Product name | First Trust NYSE Arca Biotechnology Index Fund | iShares Nasdaq Biotechnology ETF | iShares U.S. Healthcare ETF | Vanguard Health Care ETF | SPDR S&P Biotech ETF | Health Care Select Sector SPDR Fund |
| Issuer | First Trust | iShares | iShares | Vanguard | SPDR | SPDR |
| Price | $137.06 | $117.58 | $257.69 | $226.91 | $76.72 | $123.76 |
| Expense Ratio | 0.55% |  0.45% | 0.43% | 0.1% | 0.35% | 0.12% |
| Average Spread | 0.117% | 0.017% | 0.058% | 0.044% | 0.039% | 0.008% |
| AUM | $1,460,230,000 | $7,490,990,000 | $2,693,670,000 | $14,646,500,000 | $4,235,320,000 | $29,169,600,000 |
| Shares | 10,653,924 | 63,709,707 | 10,453,130 | 64,547,526 | 55,204,877 | 235,694,963 |
| Average Daily Volume | 32,637 | 1,968,141 | 59,750 | 221,097 | 11,331,733 | 10,514,720 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2006-06-19 | 2001-02-05 | 2000-06-12 | 2004-01-26 | 2006-01-31 | 1998-12-16 |
| Index Tracked | NYSE Arca Biotechnology (TR) | ICE Biotechnology Index | N/A | MSCI US Investable Market Health Care 25/50 Index | S&P Biotechnology Select Industry Index | S&P Health Care Select Sector Index |
| Category | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Large/Mid Caps | Large/Mid Caps | Large Caps | Large Caps | Mid/Small Caps | Large Caps |
| Value or Growth | Growth | Growth | Growth | Growth | Growth | Growth |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | U.S. | U.S. | U.S. | U.S. | U.S. | U.S. |
| Annual Dividend Rate | $2.214 | $0.349 | $3.089 | $3.134 | $0 | $1.964 |
| Annual Dividend Yield | 0.016% | 0.003% | 0.012% | 0.014% | 0.000% | 0.016% |
| Number of Holdings | 31 | 267 | 127 | 451 | 196 | 65 |
| YTD Return | -15.37% | -22.76% | -13.47% | -13.98% | -31.48% | -11.16% |
| Beta | 1.20 | 1.25 | 0.89 | 0.88 | 1.42 | 0.89 |
| Upside Beta | 0.06 | 0.31 | 0.25 | 0.20 | 0.12 | 0.25 |
| Downside Beta | -0.13 | 0.31 | 0.14 | 0.08 | -0.15 | 0.14 |
| Volatility 1Y | 28.39% | 28.90% | 18.63% | 19.10% | 45.75% | 18.23% |
| Sharpe Ratio 3Y | 0.09 | 0.20 | 0.91 | 0.88 | -0.12 | 1.02 |
| Treynor Ratio 3Y | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.02 |